iSpecimen Inc.
ISPC
$0.42
-$0.06-13.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.35M | 5.91M | 8.06M | 9.29M | 10.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.35M | 5.91M | 8.06M | 9.29M | 10.39M |
| Cost of Revenue | 2.63M | 3.98M | 4.96M | 5.30M | 5.41M |
| Gross Profit | 722.60K | 1.93M | 3.10M | 3.99M | 4.99M |
| SG&A Expenses | 10.27M | 10.15M | 11.30M | 13.19M | 11.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.48M | 16.91M | 19.42M | 22.02M | 20.15M |
| Operating Income | -12.13M | -11.01M | -11.37M | -12.73M | -9.76M |
| Income Before Tax | -11.53M | -10.19M | -11.25M | -12.50M | -9.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.53 | -10.19 | -11.25 | -12.50 | -9.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.53M | -10.19M | -11.25M | -12.50M | -9.52M |
| EBIT | -12.13M | -11.01M | -11.37M | -12.73M | -9.76M |
| EBITDA | -11.87M | -10.75M | -11.11M | -12.47M | -9.50M |
| EPS Basic | -6.95 | -8.57 | -11.87 | -17.52 | -18.94 |
| Normalized Basic EPS | -4.35 | -5.36 | -7.42 | -10.95 | -11.84 |
| EPS Diluted | -6.95 | -8.57 | -11.87 | -17.52 | -18.94 |
| Normalized Diluted EPS | -4.35 | -5.36 | -7.42 | -10.95 | -11.84 |
| Average Basic Shares Outstanding | 11.79M | 6.64M | 4.71M | 2.84M | 2.16M |
| Average Diluted Shares Outstanding | 11.79M | 6.64M | 4.71M | 2.84M | 2.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |